New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison

BACKGROUND: In the US, the prevalence of hepatitis C virus (HCV) has surpassed the prevalence of human immunodeficiency virus (HIV), with about 3.3 million people chronically infected with the disease. Given the aging of the Baby Boomer generation and the subsequent implementation of age-based scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Poonsapaya, Jennifer M., Einodshofer, Michael, Kirkham, Heather S., Glover, Pheophilus, DuChane, Janeen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595188/
https://www.ncbi.nlm.nih.gov/pubmed/26445564
http://dx.doi.org/10.1186/s12962-015-0043-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595188/
https://www.ncbi.nlm.nih.gov/pubmed/26445564
http://dx.doi.org/10.1186/s12962-015-0043-y

Ejemplares similares